skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)

اصطلاح مرجح

alpha-n-acetylneuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • -1

فرمول

  • C64H110N4O37R

جرم

  • 1527.565

جرم تک‌ایزوتوپی

  • 1526.68489

اسمایلٓ

  • [C@H]1(O[C@@H]([C@H](O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(C)=O)[C@@H]([C@H]1O)O[C@]3(O[C@]([C@@H]([C@H](C3)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)CO)O[C@@H]4[C@H]([C@H](O[C@@H]5[C@H]([C@H](O[C@@H]6[C@H](O[C@@H](OC[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(=O)*)[C@@H]([C@H]6O)O)CO)O[C@@H]([C@@H]5O)CO)O)O[C@H](CO)[C@H]4O)NC(C)=O

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142586

این مفهوم را بارگیری کن: